



High erythrocyte levels of the n-6 polyunsaturated
fatty acid linoleic acid are associated with lower risk
of subsequent rheumatoid arthritis in a Southern
European nested case-control study.
de Pablo, Paola; Romaguera, Dora; Fisk, Helena L; Calder, Philip C; Quirke, Anne-Marie;
Cartwright, Alison J; Panico, Salvatore; Mattiello, Amalia; Gavrila, Diana; Navarro, Carmen;
Sacerdote, Carlotta; Vineis, Paolo; Tumino, Rosario; Ollier, William E; Michaud, Dominique S;





Citation for published version (Harvard):
de Pablo, P, Romaguera, D, Fisk, HL, Calder, PC, Quirke, A-M, Cartwright, AJ, Panico, S, Mattiello, A, Gavrila,
D, Navarro, C, Sacerdote, C, Vineis, P, Tumino, R, Ollier, WE, Michaud, DS, Riboli, E, Venables, PJ & Fisher,
BA 2018, 'High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are associated with lower risk
of subsequent rheumatoid arthritis in a Southern European nested case-control study.', Annals of the Rheumatic
Diseases. https://doi.org/10.1136/annrheumdis-2017-212274
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 26/01/2018
Published in Annals of the Rheumatic Diseases on 07/02/2018
DOI: 10.1136/annrheumdis-2017-212274
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
High erythrocyte levels of the n-6 polyunsaturated fatty acid linoleic acid are 
associated with lower risk of subsequent rheumatoid arthritis in a Southern 
European nested case-control study.  
Paola de Pablo,1 Dora Romaguera,2,3 Helena L Fisk,4 Philip C Calder,4 Anne-Marie Quirke,5 Alison J 
Cartwright,5 Salvatore Panico,6 Amalia Mattiello,6 Diana Gavrila,7,8 Carmen Navarro,7,8,9 Carlotta 
Sacerdote,10 Paolo Vineis,11,12 Rosario Tumino,13 William E  Ollier,14 Dominique S Michaud,2,15 Elio 
Riboli,2 Patrick J Venables,5 Benjamin A Fisher.1 
1 Rheumatology Research Group and Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of 
Excellence (RACE), Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK 
2 School of Public Health, Imperial College London, London, UK 
3 CIBER-OBN (Fisiopatología de la Obesidad y Nutrición), and IdISBa, University Hospital Son Espases, Palma, 
Spain 
4Faculty of Medicine, University of Southampton, outhampton UK and NIHR Southampton Biomedical 
Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, 
Southampton, UK 
5 Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK 
6 Department of Clinical and Experimental Medicine, Federico II University of Naples, Naples, Italy 
7 Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain 
8 CIBER Epidemiología y Salud Pública (CIBERESP), Spain 
9 Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain 
10 Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer 
Prevention (CPO), Turin, Italy 
11 Human Genetics Foundation, Turin, Italy 
12 MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK 
13 Cancer Registry and Histopathology Unit, "Civic - M.P.Arezzo" Hospital, ASP Ragusa, Italy 
14 Centre for Integrated Genomic Medical Research, Division of Population Health, Faculty of Biology, Medicine 
and Health, University of Manchester, Manchester, UK 
15 Department of Public Health and Community Medicine, Tufts University Medical School, Boston, MA, USA 
 
Corresponding author: Dr Benjamin Fisher, Centre for Translational Inflammation Research, Queen 
Elizabeth Hospital Birmingham, Birmingham, B15 2WB, UK 
b.fisher@bham.ac.uk  
Online Supplementary Table 1. Multivariate negative binomial regression models on the association between serum cytokines and erythrocyte 




* The exponentiated regression coefficients (relative risk [RR]) have interpretation as a ratio of means. Model 1: Age- and sex-adjusted; Model 2: Model 1 with 




















 RR 95% CI* RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Fatty acids           
LA            
Model 1 1.09 (1.04-1.15) 1.0 (0.94-1.19) 0.99 (0.89-1.10) 0.84 (0.78-0.91) 0.55 (0.48-0.62) 1.07 (1.02-1.12) 0.62 (0.56-.68) 0.76 (0.65-0.88) 0.53 (0.45-0.62) 1.06 (0.98-1.14) 
Model 2 1.11 (1.06-1.17) 1.03 (0.93-1.15) 0.90 (0.78-1.04) 0.88 (0.81-0.95) 0.78 (0.69-0.89) 1.08 (1.03-1.14) 0.87 (0.78-0.96) 0.84 (0.71-0.99) 0.78 (0.66-0.91) 0.90 (0.82-0.98) 
           
n-3PUFA           
Model 1 1.12 (1.00-1.26) 0.89 (0.75-1.06) 1.51 (1.16-1.96) 0.93 (0.77-1.11) 0.30 (0.22-0.43) 0.99 (0.89-1.10) 0.32 (0.24-0.42) 0.74 (0.52-1.05) 0.27 (0.18-0.41) 0.95 (0.77, 1.16) 
Model 2 1.09 (0.97-1.23) 0.86 (0.72-1.01) 1.45 (1.10-1.93) 1.01 (0.84-1.21) 0.88 (0.67-1.16) 0.96 (0.87-1.07) 0.88 (0.71-1.09) 0.91 (0.62-1.34) 0.85 (0.60-1.19) 0.78 (0.64-0.95) 
           
n-6 PUFA           
Model 1 1.06 (1.02-1.10) 1.07 (1.00-1.15) 0.99 (0.88-1.12) 0.88 (0.82-0.93) 0.63 (0.59-0.67) 1.05 (1.02-1.09) 0.69 (0.66-0.73) 0.77 (0.71-0.85) 0.61 (0.56-0.66) 1.11 (1.05-1.17) 
Model 2 1.06 (1.01-1.10) 1.12 (1.04-1.19) 0.99 (0.88-1.12) 0.92 (0.86-0.98) 0.81 (0.75-0.88) 1.06 (1.02-1.10) 0.87 (0.81-0.92) 0.80 (0.73-0.88) 0.81  (0.73-0.90) 0.99 (0.93, 1.06) 
            
Ratio n-3/n-6**           
Model 1 1.15 (0.64-2.07) 0.38 (0.16-0.92) 4.70 (1.27-17.3) 3.07 (1.22-7.68)    228 67-777) 0.67 (0.40-1.12) 244 (83-720) 10.9 (2.30-51.45) 339 (75-1539) 0.31 (0.11-0.87) 
Model 2 1.04 (0.57-1.90) 0.24 (0.10-0.57) 5.54 (1.30-23.5) 2.43 (0.97-6.08) 6.12 (1.70-22) 0.62 (0.37-1.06)   3.54 (1.27-9.83) 11.7 (2.65-51.55) 7.06 (1.41-35.24) 0.48 (0.18-1.27) 
Online Supplementary Table 2. Multivariate negative binomial regression models on the association between serum cytokines and erythrocyte 






















 RR 95% CI* RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI RR 95% CI 
Fatty acids           
LA            
Model 1 1.12 (1.05-1.18)  1.03 (0.88-1.21) 1.04 (0.90-1.20) 0.97 (0.85-1.11) 0.99 (0.87-1.13) 0.84 (0.78-0.91) 0.99 (0.89-1.09)   0.91 (0.77-1.06) 1.01 (0.86-1.18) 1.08 (0.98-1.19) 
Model 2 1.13 (1.05-1.22) 1.21 (1.02-1.43) 1.02 (0.85-1.23) 1.03 (0.88-1.22) 0.84 (0.71-0.98) 0.86 (0.78-0.95) 0.93 (0.83-1.05) 0.79 (0.64-0.97) 0.80 (0.66-0.97) 1.07 (0.95-1.21) 
           
n-3 PUFA            
Model 1 0.92 (0.77-1.08) 0.84 (0.57-1.26) 0.92 (0.63-1.35) 0.93 (0.65-1.32) 1.04 (0.73-1.46) 1.16 (0.95-1.43)  0.93 (0.73-1.20) 0.97 (0.65-1.42) 1.16 (0.77-1.75) 0.95 (0.73-1.22) 
Model 2 0.87 (0.73-1.02) 0.81 (0.54-1.23) 0.85 (0.55-1.32) 0.87 (0.60-1.26) 0.93 (0.65-1.34) 1.09 (0.89-1.34) 0.89 (0.67-1.17) 0.99 (0.64-1.55) 1.00 (0.64-1.56) 0.90 (0.68-1.19) 
           
n-6 PUFA            
Model 1   1.05 (0.99-1.10) 1.07 (0.96-1.20)   1.08 (0.96-1.22) 1.03 (0.92-1.14) 0.99 (0.89-1.10) 0.97 (0.91-1.03) 1.01  (0.93-1.08) 0.98 (0.87-1.11) 1.00 (0.88-1.14) 1.06 (0.98-1.15) 
Model 2   1.03 (0.97-1.09) 1.19 (1.05-1.35) 1.06 (0.92-1.21) 1.05 (0.93-1.19) 0.95 (0.86-1.06) 1.00 (0.944-1.07) 0.99 (0.91-1.07) 0.93 (0.80-1.07) 0.94 (0.83-1.08) 1.05 (0.96-1.15) 
           
Ratio n-3/n-6**            
Model 1 0.36 (0.15-0.86) 0.15 (0.02-1.27) 0.22 (0.02-1.95) 0.52 (0.07-3.77) 1.32 (0.21-7.93) 3.23 (0.97-10.7) 0.68 (0.18-2.55) 1.12 (0.12-10.25) 1.98 (0.22-17.6) 0.33 (0.08-1.37) 
Model 2 0.33 (0.14-0.82) 0.06 (0.01-0.53) 0.25 (0.02-2.54) 0.32 (0.04-2.50) 1.45 (0.24-8.87) 1.49 (0.42-5.20) 0.69 (0.17-2.74) 2.05 (0.18-22.44) 1.82 (0.20-16.3) 0.34 (0.08-1.51) 
* The exponentiated regression coefficients (relative risk [RR]) have interpretation as a ratio of means. Model 1: Age- and sex-adjusted; Model 2: Model 1 with further 
adjustment for BMI, country of origin and smoking status. ** Log-transformed for analyses. Results in bold indicate p<0.05. 
 
 
